The Fragile Recovery Meets Structural Pressures

The US hospital industry entered 2026 with cautious optimism that is rapidly giving way to strategic urgency. After years of gradual financial improvement, “the tone for the sector has turned more cautious,” according to Fitch Ratings analysis of 222 not-for-profit hospitals. The current operational recovery “may be at or very near a transition point” as healthcare systems brace for the full force of federal policy changes.

The fragility is visible in the numbers. According to Strata Decision Technology data from more than 1,900 hospitals, the average health system margin hit 0.4% in March 2026 after two months in negative territory. Hospital operating margins reached 2.5% on average in March, a slight improvement from February, but the underlying pressures tell a more complicated story.

The K-Shaped Divergence Deepens

The recovery is not evenly distributed. AA-rated systems saw median operating margins improve to 2.8% in fiscal 2025, near pre-pandemic levels, while junk-rated hospitals saw their margins fall to -2.8% from -1.6% the prior year. Record cash-to-debt ratios were driven by investment gains that were “almost entirely an upper-tier phenomenon,” with BBB and junk-rated systems reporting sharp declines in cash holdings—days cash on hand falling 22% and 31% respectively.

Kevin Holloran, senior director at Fitch Ratings, predicts a bifurcation between “have” and “have-not” hospitals based on location, willingness to make hard decisions on mission versus margin, and ability to realize operational opportunities. “It’s recognizing you can’t be all things to all people in all places,” he said.

The Outpatient Imperative: Where Growth Lives

Outpatient care is the clear driver of hospital revenue growth in 2026. According to Kaufman Hall data, outpatient revenue grew 8% nationally in Q1 2026, outpacing inpatient revenue growth of just 4%. The gap was even wider in March, with outpatient revenue jumping 11.8% year over year compared to a 6.6% increase in inpatient revenue.

Policy changes are accelerating this shift. Medicare’s 2026 Outpatient Prospective Payment System rule will cut reimbursement for drug administration at some off-campus hospital outpatient departments to 40% of prior OPPS rates, and the inpatient-only list will be phased out by year-end 2027, sustaining volume and margin growth for ambulatory surgery centers.

The Outpatient Shift Tradeoff

The outpatient shift comes with tradeoffs. As more care moves to outpatient settings, hospitals face revenue dilution and a higher concentration of complex, high-acuity patients on the inpatient side. Volume trends reinforce this dynamic: discharges per calendar day fell 2%, adjusted patient days declined 1%, average length of stay dropped 4%, and emergency department visits decreased 5%.

But the financial math has shifted decisively toward outpatient care. Labor and non-labor expenses remain elevated, with nonlabor expense increasing 9% through May, reflecting continued inflationary pressures. ASCs carry lower fixed costs and less reimbursement exposure than hospitals, making them increasingly attractive.

The ASC Land Grab: Consolidation at Unprecedented Scale

The Ascension-AmSurg Deal

Health systems, private equity firms, and payers are racing to acquire outpatient assets. The scale is dramatic. Ascension completed its $3.9 billion acquisition of AmSurg, expanding its ASC network to roughly 300 facilities nationwide. AmSurg controls roughly 3.9% of the ASC market with 250-plus centers across 34 states and partners with about 2,000 physicians. Ascension itself went from running 139 hospitals in 2022 to operating 90 hospitals and more than 300 ASCs by June 2026.

Amber Sims, Ascension’s executive vice president and chief strategy and growth officer, explained: “We had to get ahead in the ambulatory business, because that’s where care is going. It’s where patients want to receive care, where payers want to seek care, and where providers want to provide care”.

For-Profit Speed Gap

The four largest publicly traded hospital companies are deploying outpatient capital at pace. Tenet Healthcare deployed $125 million in Q1 2026 to acquire seven ASCs, representing half of its annual M&A target for USPI, which now operates nearly 570 assets. Community Health Systems is purchasing a majority stake in an ASC operator in Anchorage, opening de novo ASCs in Alabama, and acquiring the Surgical Institute of Alabama—an 8,000+ annual case facility and its largest acquisition since 2016. HCA continued outpatient acquisitions in urgent care, ASC, and freestanding ED platforms.

The strategic pattern is consistent across for-profits. High-acuity surgical work—total joints, robotics-enabled general surgery, urology—is migrating outpatient at scale, and multispecialty ASCs in growth markets are the highest-margin growth vehicle available.

FTC Scrutiny Signals a New Era

The Ascension-AmSurg deal did not close cleanly. The FTC required seven divestitures across five states before approving the transaction, which is the first time federal regulators applied that level of scrutiny to an ASC-specific deal. The consent order requires Ascension to provide prior notice before acquiring any ASCs in the affected metropolitan areas for 10 years.

The FTC’s framework was explicitly local. “The FTC is defining ASCs as highly localized monopoly markets,” Sean Gipson, CEO of Houston-based Remedy Surgery Center, told Becker’s. “Competition is not national or even statewide—it is metro-area specific and service-line specific”. This standard has direct implications for any operator building density in a single market.

The Policy Storm: $510 Billion in Cuts Beyond Statutory Intent

The One Big Beautiful Bill Act

The dominant threat to hospital credit profiles is the One Big Beautiful Bill Act (H.R. 1), enacted in 2025. The law imposes 80-hour monthly work requirements for Medicaid expansion adults ages 19 to 64, effective January 2027, and cuts nearly $1 trillion from Medicaid over 10 years.

CMS Proposed Rule: 3.4 Times More Than Congress Intended

The rule implementing OBBBA provisions would increase federal funding cuts to $510 billion over 10 years—3.4 times more than what Congress intended. The law included SDP changes that would cut nearly $150 billion over 10 years; CMS’s rule expands those cuts significantly.

America’s Essential Hospitals estimated OBBBA will increase hospital uncompensated care costs by $466 billion over 10 years.

State-Level Impacts

State responses highlight the geographic concentration of exposure. Although Kentucky is only the twenty-sixth most populous state, its $4.3 billion SDP is tied with two other states as the sixth largest. Sweetwater Hospital in Tennessee warned the rule’s SDP phase-down approach would cut more than $320 million annually from hospitals in the state. Louisiana is the twenty-fifth most populous state and tied for sixth largest SDP ($4.3 billion), covering 30% of its population through Medicaid.

Paul Salles, president and CEO of the Louisiana Hospital Association, wrote that the rule’s cuts would “inevitably force hospitals to reduce services, defer capital investments, delay workforce initiatives or reconsider access points that are already financially vulnerable”.

446 Hospitals at Risk

Protect Our Care, a Democratic-aligned advocacy group, reports tracking over 400 hospitals at risk of closure or cuts due to OBBBA. More than 80 hospital wards—including maternity and pediatric units—have already shuttered. The group found that more than 1,000 hospitals, clinics, hospital wards, nursing homes, and providers are closing, cutting services, or at risk.

Rural and urban safety-net hospitals are both affected. Rural hospitals often operate on thin margins serving a significant percentage of Medicaid patients, but urban safety-net hospitals face the same exposure for the same reason: many of their patients rely on Medicaid.

Implementation Timeline: The Backloaded Cliff

The cuts are heavily backloaded. Only 6% of total cuts take effect from 2025 to 2027 (ramp-up). From 2028 to 2034, the remaining 76% of funding reductions take effect, increasing pressure on states to fund programs from general revenues, reduce optional benefits, or narrow provider networks. This timetable gives hospitals time to adapt, but the delayed impact means the full weight of the cuts will arrive after the 2026 midterm elections.

The Credibility Era: GEO for Healthcare

From SEO to GEO

As patients increasingly use AI search and chatbots to find health information, health system marketers are pivoting from SEO to GEO—generative engine optimization. AI search visits grew 42.8% year over year, rising from 15.6 billion in Q1 2025 to 27.4 billion in Q1 2026. Sixteen percent of Americans now turn to chatbots such as ChatGPT and Gemini for medical advice, according to a recent Gallup poll.

How Health Systems Are Responding

Marketing leaders across the country are reorienting strategies to the AI-driven discovery era:

SSM Health is changing the way it writes and distributes content to optimize “patient and consumer understanding and AI interpretation” while connecting audiences back to its owned platforms. Ashley Pollard, vice president of marketing, captured the shift: “The traditional model where consumers ask Google a question and navigate multiple websites for answers is becoming obsolete. As AI evaluates every digital touchpoint, a holistic focus on the quality, credibility and structure of our content across the entire digital ecosystem is no longer optional—it is essential”.

Banner Health is “auditing and modernizing legacy content, using performance data and external search optimization tools to identify gaps and emerging patient intent,” while restructuring content to answer natural-language queries more directly and shoring up physician attribution. “Our focus has shifted from traffic volume alone to high-intent visibility and conversion,” said Don Stanziano, senior vice president and chief marketing officer.

Intermountain Health is “trading pageviews for high-intent engagement,” no longer relying on web traffic as a performance benchmark. Chief Marketing and Communications Officer Megan Mahncke explained: “Instead, our goal is to be a reliable source that AI tools reference in their search results. Success is measured by consumer conversion after that first discovery”.

NYU Langone Health is “laser-focused on showing up as a trusted and authoritative source” within AI platforms, ensuring “AI tools recognize NYU Langone Health as a leading clinical authority and source of truth”. Elizabeth Golden, executive vice president for communications, marketing, government and community relations, said: “Our goal is not just maintaining online traffic, but ensuring we remain a leading destination that patients trust and choose”.

CommonSpirit Health is leaning into nonpaid, credible content. Chief Marketing Officer Adam Rice said: “Building on a strong SEO foundation, we are restructuring content for AI readability and implementing technical standards that improve how large language models interpret and accurately cite our trusted health information”.

Universal Health Services is putting “emphasis on building continued trust and credibility through service-line-specific video content, including doctor/expert-led explainer videos and patient and community endorsements, and actively managing Google reviews—key strategies in a time of rising health misinformation”. Roselle Charlier, VP and chief marketing and communications officer, also noted the organization is “focused on SEO and AEO (answer engine optimization)—enabling prospective patients and their loved ones to easily access timely, relevant information”.

How AI Engines Pick Sources

AI engines reward content that is structured, sourced, and verifiable. Evidence matters more than tone:

  • Adding statistics increases AI visibility by 22%
  • Adding quotations raises it by 37%
  • Cited text is nearly twice as likely to contain definitive language: 36.2% versus 20.3%
  • 44.2% of ChatGPT citations come from the first 30% of page text
  • 65% of AI bot hits target content published within the past year

Build Expert-Reviewed Content

Expert review is the foundation of healthcare GEO. Every clinical page should name the reviewing physician, list credentials, show a review date, and link to current medical literature. These signals tell AI engines the content is accountable and protect patients from inheriting errors.

Structure Pages for Extraction

AI engines extract structured content far more reliably than prose. The format gap is large: tables get extracted by LLMs at 81% versus 23% for prose. Use clear question-style headings, short answer paragraphs, comparison tables, and FAQ blocks. Add medical schema markup—MedicalOrganization, Physician, MedicalCondition, and FAQPage—so AI engines can parse authorship, conditions, and procedures without guessing.

Real-World GEO Results

A medical GEO case study showed AI visibility improved from 18% to 44% (+26%), SOV increased 133%, brand citations rose 157%, and semantic hallucination rates dropped from 22% to 9% over a 5-month optimization period. These gains are within a reasonable engineering optimization range—30% to 80%—suggesting systematic improvements rather than statistical noise.

Key Takeaways for Hospital Marketing Leaders

1. The outpatient speed gap matters. Health systems are decoupling outpatient facilities from central hospital overhead. If your system is still planning while competitors execute, address that gap.

2. Build comprehensive content clusters with expert review. Specialized condition and treatment pages with named physician reviewers are required—not one-page overviews.

3. Optimize for GEO, not just SEO. AI search visits grew 42.8% year-over-year. Your content must be structured, sourced, and verifiable for AI extraction.

4. Technical foundations are non-negotiable. Schema markup, accessibility, internal linking, and AI crawler access are critical for both search and AI visibility.

5. Credibility is the new currency. Systems investing in expert-reviewed, structured content earn AI citations and patient trust.

6. Quantify policy exposure. Rating agencies and boards are asking: What’s your Medicaid hit? What’s your mitigation plan?

Conclusion

The US hospital industry in 2026 is navigating structural pressures: a K-shaped recovery widening the gap between winners and losers, $510 billion in Medicaid cuts beyond statutory intent, a massive ASC consolidation wave, and a patient discovery layer increasingly dominated by AI answer engines.

The for-profit speed gap is clear. Tenet, CHS, and HCA are deploying outpatient capital at scale while many NFP systems remain in the planning phase. As healthcare marketers prepare for 2027, those who invest in structured, expert-reviewed content, technical excellence, and AI-optimized visibility will capture patients in a system where demand outpaces supply. In an era of AI-mediated discovery, credibility is not just a marketing tactic—it is a survival strategy.